Author:
Lao-Sirieix Pierre,Fitzgerald Rebecca C.
Reference74 articles.
1. Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D et al. (2000) Prospective study of cyclin D1 overexpression in Barrett’s esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst 92(16): 1316–1321.
2. Barrett MT, Pritchard D, Palanca-Wessels C, Anderson J, Reid BJ, Rabinovitch PS (2003) Molecular phenotype of spontaneously arising 4 N (G2-tetraploid) intermediates of neoplastic progression in Barrett’s esophagus. Cancer Res 63(14): 4211–4217.
3. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG et al. (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22(1): 106–109.
4. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G et al. (2002) Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111(2): 251–263.
5. Boynton RF, Huang Y, Blount PL, Reid BJ, Raskind WH, Haggitt RC et al. (1991) Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res 51(20): 5766–5769.